Suppr超能文献

相似文献

2
Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer.
Vet Pathol. 2010 Mar;47(2):265-74. doi: 10.1177/0300985809353167. Epub 2009 Dec 31.
3
Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366.
PLoS One. 2015 Mar 25;10(3):e0122277. doi: 10.1371/journal.pone.0122277. eCollection 2015.
4
Canine cell line, IPC-366, as a good model for the study of inflammatory breast cancer.
Vet Comp Oncol. 2017 Sep;15(3):980-995. doi: 10.1111/vco.12238. Epub 2016 May 5.
5
Cell adhesion molecules E-cadherin and CADM1 are differently expressed in canine inflammatory mammary cancer.
Res Vet Sci. 2022 Dec 20;152:307-313. doi: 10.1016/j.rvsc.2022.08.027. Epub 2022 Aug 31.
6
Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer.
Vet Immunol Immunopathol. 2013 Apr 15;152(3-4):245-51. doi: 10.1016/j.vetimm.2012.12.010. Epub 2012 Dec 29.
7
Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
Vet J. 2013 Aug;197(2):427-32. doi: 10.1016/j.tvjl.2013.02.009. Epub 2013 Mar 11.
9
Metastasis of canine inflammatory versus non-inflammatory mammary tumours.
J Comp Pathol. 2010 Aug-Oct;143(2-3):157-63. doi: 10.1016/j.jcpa.2010.02.002. Epub 2010 Apr 27.
10
Establishment of a new cell line of canine inflammatory mammary cancer: IMC-118.
Vet Comp Oncol. 2022 Sep;20(3):679-687. doi: 10.1111/vco.12822. Epub 2022 May 25.

引用本文的文献

本文引用的文献

1
Overview of advances in vasculogenic mimicry - a potential target for tumor therapy.
Cancer Manag Res. 2018 Aug 2;10:2429-2437. doi: 10.2147/CMAR.S164675. eCollection 2018.
5
Incidence of inflammatory breast cancer in patients with clinical inflammatory breast symptoms.
PLoS One. 2017 Dec 20;12(12):e0189385. doi: 10.1371/journal.pone.0189385. eCollection 2017.
6
Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin.
Mol Cancer. 2017 Mar 21;16(1):65. doi: 10.1186/s12943-017-0631-x.
7
Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.
Nat Med. 2016 Nov;22(11):1294-1302. doi: 10.1038/nm.4197. Epub 2016 Oct 17.
9
Escaping Antiangiogenic Therapy: Strategies Employed by Cancer Cells.
Int J Mol Sci. 2016 Sep 6;17(9):1489. doi: 10.3390/ijms17091489.
10
Targeting Angiogenesis in Cancer Treatments: Where do we Stand?
J Pharm Pharm Sci. 2016 Apr-Jun;19(2):226-38. doi: 10.18433/jpps.v19i2.27608.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验